Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeen Regulatory News (SEEN)

Share Price Information for Seeen (SEEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.75
Bid: 3.50
Ask: 4.00
Change: -0.65 (-14.77%)
Spread: 0.50 (14.286%)
Open: 4.40
High: 4.40
Low: 3.75
Prev. Close: 4.40
SEEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of GM and Open Offer

23 Dec 2022 09:44

RNS Number : 9119K
SEEEN PLC
23 December 2022
 

 

23 December 2022

 

SEEEN plc

 

("SEEEN", the "Group", or the "Company")

 

 

Result of General Meeting

 

Result of Open Offer

 

Total Voting Rights

 

SEEEN plc (AIM: SEEEN), the media and technology platform that delivers Key Video Moments to drive increased views and revenues across video content, announces the results of the voting on the Resolutions put to its General Meeting held earlier today. All Resolutions put to Shareholders at the meeting were duly passed.

The Company also announces the results of the Open Offer pursuant to the Fundraising announced on 7 December 2022. The Company received valid acceptances from Qualifying Shareholders in respect of a total of 523,887 Open Offer Shares. All Qualifying Shareholders who have validly applied for Open Offer Shares will receive their full and excess entitlements. Additionally, the Joint Brokers have confirmed to the Company that the Broker Option has not been exercised. Accordingly, the Company is pleased to confirm that as a result of obtaining Shareholder approval for the Fundraising and Capital Reorganisation, the Fundraising has raised total gross proceeds of approximately £2.6 million.

The net proceeds of the Fundraising are intended to be used by the Group primarily to bolster the sales and marketing team and invest into technology development projects to support its planned next stage of growth.

Total Voting Rights

The Company has applied for Admission of the Fundraising Shares to trading on AIM. Admission is anticipated to occur at 8.00 a.m. on 30 December 2022.

Upon Admission and following the Capital Reorganisation having become effective, the total number of ordinary shares of 0.1p in issue and voting rights in the Company will be 93,345,815. The Company does not hold any shares in treasury.

From Admission, the above figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the ordinary share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Director and significant shareholdings

Following Admission, the revised holdings of the Directors who are interested in the Company's ordinary shares of 0.1p will be as set out in the table below:

 

Name

Board role

Number of Placing Shares to be acquired on Admission

Number of ordinary shares held following Admission

Percentage of enlarged share capital following Admission

 

 

 

 

 

Adrian Hargrave

Chief Executive Officer

583,333

788,333

0.84%

Dr Patrick DeSouza*

Non-Executive Chairman

-

5,426,165

5.81%

 

* This represents the interest of a related trust, of which Dr DeSouza's immediate family are the sole beneficiaries. Dr DeSouza is the trustee of the trust.

 

In addition, as a result of the issue of the Fundraising Shares, the Company is aware of the following interests of certain significant shareholders (as defined in the AIM Rules for Companies) in the Company, which will be revised following Admission:

 

Name

Number of Placing Shares to be acquired on Admission

Number of Ordinary Shares held following Admission

Percentage of enlarged share capital following Admission

 

 

 

 

Water Intelligence plc**

2,083,333

5,938,366

6.36%

 

** Dr DeSouza is a director of Water Intelligence plc and Dr DeSouza is interested in 25.07% of Water Intelligence plc's issued share capital.

 

Capitalised terms used in this announcement shall, unless defined in this announcement or unless the context provides otherwise, bear the same meaning ascribed to such terms in the announcement made by the Company at 18:25 on 7 December 2022 and the Company's Circular.

 

For further information please contact:

 

SEEEN plc

Adrian Hargrave, CEO 

Tel: +44 (0)7775 701 838

Website: seeen.com 

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: +44 (0)20 3328 5656

Alex Brearley / George Payne (Corporate Finance)

Tony Quirke / Amrit Nahal (Sales and Corporate Broking)

 

Dowgate Capital Limited - (Joint Broker)

Stephen Norcross

 

Tel: +44(0)20 3903 7721

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROIGCBDDXSDDGDX
12
Date   Source Headline
1st Mar 20247:00 amRNSPartnership with the American 7s Football League
2nd Feb 20247:00 amRNSDirector dealings
1st Feb 20247:00 amRNSTrading Update and Board Change
18th Jan 20247:00 amRNSPartnership with the London Broncos
29th Sep 20237:00 amRNSInterim Results
26th Sep 202311:57 amRNSHolding(s) in Company
6th Sep 20237:00 amRNSTechnology Day
24th Aug 20237:00 amRNSDirector dealing
26th Jul 202312:23 pmRNSResult of AGM
26th Jul 20237:00 amRNSLaunch of CreatorSuite 2.0
30th Jun 20237:00 amRNSResults for the year ended 31 December 2022
7th Jun 20237:00 amRNSAttendance at UK Investor Show
18th May 20237:00 amRNSAppointment of Non-Executive Director and CFO
6th Feb 20237:00 amRNSTrading Update, Customer Win and Board Change
11th Jan 202312:22 pmRNSHolding(s) in Company
4th Jan 20231:15 pmRNSHolding(s) in Company
30th Dec 20221:00 pmRNSTotal Voting Rights
28th Dec 20227:00 amRNSHolding(s) in Company
28th Dec 20227:00 amRNSHolding(s) in Company
23rd Dec 20229:44 amRNSResult of GM and Open Offer
7th Dec 20226:25 pmRNSFundraise and other matters
7th Dec 20226:22 pmRNSAppointment of Nominated Adviser and Joint Broker
8th Nov 20225:27 pmRNSHolding(s) in Company
28th Oct 20225:13 pmRNSHolding(s) in Company
29th Sep 20227:00 amRNSInterim Results
26th Aug 20225:07 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSHolding(s) in Company
17th Aug 20227:00 amRNSDirector/PDMR Shareholding
28th Jul 20224:59 pmRNSResult of AGM
11th Jul 20227:01 amRNSCustomer Win - Daily Mail
11th Jul 20227:00 amRNSCEO Appointment
6th Jul 20227:00 amRNSCustomer Wins
30th Jun 20227:00 amRNSFinal Results and Notice of AGM
31st May 20227:00 amRNSHolding(s) in Company
31st May 20227:00 amRNSDirector Shareholding and Notice of Results
27th May 20227:00 amRNSBoard Appointment Confirmation
25th Apr 20224:41 pmRNSSecond Price Monitoring Extn
25th Apr 20224:36 pmRNSPrice Monitoring Extension
7th Apr 20227:00 amRNSContract Wins
16th Mar 20227:00 amRNSDirector Changes, Business Update
23rd Feb 20227:00 amRNSStrategic Partnership with Kinetiq, Inc
3rd Feb 20227:00 amRNSTrading Update
27th Jan 20227:00 amRNSContract Wins and Notice of Trading Update
2nd Dec 20217:00 amRNSContract Wins and 3Q Trading Update
29th Sep 20217:00 amRNSHalf-year Report
20th Sep 20217:00 amRNSNotice of Results
4th Aug 20217:00 amRNS1H Trading Update and Director Change
29th Jul 20217:00 amRNSResult of AGM
29th Jun 20217:00 amRNSFinal Results and Notice of AGM
17th Jun 202111:00 amRNSNotice of Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.